ATE400256T1 - Pharmazeutische zusammensetzung mit einem kationischen hilfsmittel - Google Patents

Pharmazeutische zusammensetzung mit einem kationischen hilfsmittel

Info

Publication number
ATE400256T1
ATE400256T1 AT04793869T AT04793869T ATE400256T1 AT E400256 T1 ATE400256 T1 AT E400256T1 AT 04793869 T AT04793869 T AT 04793869T AT 04793869 T AT04793869 T AT 04793869T AT E400256 T1 ATE400256 T1 AT E400256T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
cationic excipient
composition containing
excipient
cationic
Prior art date
Application number
AT04793869T
Other languages
English (en)
Inventor
Helena Ljusberg-Wahren
Dan Lundberg
Krister Holmberg
Original Assignee
Camurus Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Camurus Ab filed Critical Camurus Ab
Application granted granted Critical
Publication of ATE400256T1 publication Critical patent/ATE400256T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04793869T 2003-11-05 2004-10-29 Pharmazeutische zusammensetzung mit einem kationischen hilfsmittel ATE400256T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0302924A SE0302924D0 (sv) 2003-11-05 2003-11-05 Pharmaceutical composition having a cationic excipient

Publications (1)

Publication Number Publication Date
ATE400256T1 true ATE400256T1 (de) 2008-07-15

Family

ID=29707847

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04793869T ATE400256T1 (de) 2003-11-05 2004-10-29 Pharmazeutische zusammensetzung mit einem kationischen hilfsmittel

Country Status (6)

Country Link
US (2) US20070031485A1 (de)
EP (1) EP1684730B1 (de)
AT (1) ATE400256T1 (de)
DE (1) DE602004014964D1 (de)
SE (1) SE0302924D0 (de)
WO (1) WO2005044237A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101691335B (zh) * 2009-10-26 2013-03-27 大庆市富杰化工有限公司 羧酸高碳醇酯基三甲基氯化铵及在粘土稳定剂中的应用
US8791045B2 (en) 2011-11-09 2014-07-29 Kimberly-Clark Worldwide, Inc. Non-tacky wetness indicator composition for application on a polymeric substrate
US9889222B2 (en) 2011-11-09 2018-02-13 Kimberly-Clark Worldwide, Inc. Aqueous medium-sensitive coating compositions for triggered release of active ingredients and visual indication for wetness
US9585826B2 (en) 2012-11-07 2017-03-07 Kimberly-Clark Worldwide, Inc. Triggerable compositions for two-stage, controlled release of active chemistry
US9119780B2 (en) 2013-10-30 2015-09-01 Kimberly-Clark Worldwide, Inc. Triggerable compositions for two-stage, controlled release of proactive chemistry
US12433850B2 (en) 2016-05-05 2025-10-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
JP7653218B2 (ja) 2016-05-05 2025-03-28 アクエスティブ セラピューティクス インコーポレイテッド 送達増強エピネフリン組成物
US12427121B2 (en) 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
IL273477B2 (en) * 2017-09-26 2024-08-01 Aquestive Therapeutics Inc Delivery pharmaceutical compositions including permeation enhancers
US12465564B2 (en) 2021-10-25 2025-11-11 Aquestive Therapeutics, Inc. Oral and nasal compositions and methods of treatment

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE466134B (sv) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande baerarkomposition samt anvaendning daerav i farmaceutiska kompositioner
US5389676A (en) * 1991-03-22 1995-02-14 E. B. Michaels Research Associates, Inc. Viscous surfactant emulsion compositions
IL101241A (en) * 1992-03-16 1997-11-20 Yissum Res Dev Co Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
US5830430A (en) * 1995-02-21 1998-11-03 Imarx Pharmaceutical Corp. Cationic lipids and the use thereof
JPH11504028A (ja) * 1995-04-24 1999-04-06 イースム リサーチ ディベロップメント カンパニー オブ ザ ヒーブル ユニバーシティ オブ エルサレム 油／水エマルジョンを作り出す自己乳化性配合物
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6881420B2 (en) * 2000-06-23 2005-04-19 Teva Pharmaceutical Industries Ltd. Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation
US7611725B2 (en) * 2002-01-31 2009-11-03 Croda, Inc. Additives and products including oligoesters
US20040062778A1 (en) * 2002-09-26 2004-04-01 Adi Shefer Surface dissolution and/or bulk erosion controlled release compositions and devices

Also Published As

Publication number Publication date
EP1684730A1 (de) 2006-08-02
SE0302924D0 (sv) 2003-11-05
DE602004014964D1 (de) 2008-08-21
US20070031485A1 (en) 2007-02-08
US20130267585A1 (en) 2013-10-10
EP1684730B1 (de) 2008-07-09
WO2005044237A1 (en) 2005-05-19

Similar Documents

Publication Publication Date Title
BRPI0409516A (pt) composição, uso de uma composição e processo de melhora da penetração de um ativo farmacêutico
AR018109A1 (es) FORMULACIoN GALÉNICA ADMINISTRABLE POR VíA ORAL QUE PERMITE UNA ABSORCIoN MEJORADA DE PRINCIPIOS ACTIVOS, USO DE UN AGENTE MAJORADOR DE ABSORCIoN PARA PREPARAR UNA FORMA DE DOSIFICACIoN ADMINISTRABLE POR VíA ORAL Y PROCEDIMIENTO PARA PREPARAR DICHA FORMULACIoN GALÉNICA
BR0107869A (pt) Composições farmacêuticas eletrogiradas
ATE356612T1 (de) Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit
DE60021570D1 (de) Neue zubereitung und darreichungsform enthaltend einen säurelabilen protonenpumpeninhibitor
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
EA200200812A1 (ru) Фармацевтическая композиция, содержащая низкую дозу энтекавира, и ее применение
ATE260647T1 (de) Mechanisch stabile pharmazeutische darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive substanzen
ATE400256T1 (de) Pharmazeutische zusammensetzung mit einem kationischen hilfsmittel
AR034813A1 (es) Composiciones farmaceuticas y uso de las mismas
DE60019334D1 (de) Antivirale arznei
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
WO2002030467A3 (en) Pharmaceutical composition containing honey for the treatment of wounds
AR039166A1 (es) Composiciones de venlafaxina base
ATE464878T1 (de) Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl
AR031679A1 (es) Una composicion farmaceutica
AR036321A1 (es) Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia.
ATE199495T1 (de) Pharmazeutische zubereitung zur direktverpressung
SE9802209D0 (sv) Novel compounds
BRPI0515555A (pt) composição farmacêutica compreendendo éster de temozolomida
ATE385786T1 (de) Pharmazeutische zusammensetzung in form eines hydrogels zur transdermalen verabreichung von wirkstoffen
AR022462A1 (es) Uso de un agente que disminuye el colesterol
AR040287A1 (es) Plataforma para formulaciones transdermicas (pft)
AR048672A1 (es) Tabletas de desintegracion que comprenden licarbazepina

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties